All lobbying filings
Endgame Strategies, LLC
Endgame Strategies, LLC filed a Q3 report for Campaign for Sustainable Drug Pricing (CSRXP) on October 20, 2026, reporting $30,000 in lobbying income.
Lobbying for Campaign for Sustainable Drug Pricing (CSRXP) · Coalition to promote lowering prescription drug prices.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
1
-
STEVEN DUFFIELD New on this filingPreviously held: Senate Republican Conference (Chief Counsel/Policy Director); Senate Republican Policy Committee (Deputy Staff Director; Judiciary Policy Analyst/Counsel)
Government bodies contacted
1
Lobbying activity
2
Issues relating to drug pricing and patent policy.
Issues relating to drug pricing and patent policy.